Skip to main content
Journal cover image

A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.

Publication ,  Journal Article
Bartholf DeWitt, S; Eward, WC; Eward, CA; Lazarides, AL; Whitley, MJ; Ferrer, JM; Brigman, BE; Kirsch, DG; Berg, J
Published in: Vet Surg
August 2016

OBJECTIVE: To assess the ability of a novel imaging system designed for intraoperative detection of residual cancer in tumor beds to distinguish neoplastic from normal tissue in dogs undergoing resection of soft tissue sarcoma (STS) and mast cell tumor (MCT). STUDY DESIGN: Non-randomized prospective clinical trial. ANIMALS: 12 dogs with STS and 7 dogs with MCT. METHODS: A fluorescent imaging agent that is activated by proteases in vivo was administered to the dogs 4-6 or 24-26 hours before tumor resection. During surgery, a handheld imaging device was used to measure fluorescence intensity within the cancerous portion of the resected specimen and determine an intensity threshold for subsequent identification of cancer. Selected areas within the resected specimen and tumor bed were then imaged, and biopsies (n=101) were obtained from areas that did or did not have a fluorescence intensity exceeding the threshold. Results of intraoperative fluorescence and histology were compared. RESULTS: The imaging system correctly distinguished cancer from normal tissue in 93/101 biopsies (92%). Using histology as the reference, the sensitivity and specificity of the imaging system for identification of cancer in biopsies were 92% and 92%, respectively. There were 10/19 (53%) dogs which exhibited transient facial erythema soon after injection of the imaging agent which responded to but was not consistently prevented by intravenous diphenhydramine. CONCLUSION: A fluorescence-based imaging system designed for intraoperative use can distinguish canine soft tissue sarcoma (STS) and mast cell tumor (MCT) tissue from normal tissue with a high degree of accuracy. The system has potential to assist surgeons in assessing the adequacy of tumor resections during surgery, potentially reducing the risk of local tumor recurrence. Although responsive to antihistamines, the risk of hypersensitivity needs to be considered in light of the potential benefits of this imaging system in dogs.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Vet Surg

DOI

EISSN

1532-950X

Publication Date

August 2016

Volume

45

Issue

6

Start / End Page

715 / 722

Location

United States

Related Subject Headings

  • Veterinary Sciences
  • Sarcoma
  • Prospective Studies
  • Neoplasm, Residual
  • Neoplasm Recurrence, Local
  • Mastocytoma
  • Female
  • Dogs
  • Dog Diseases
  • Biopsy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bartholf DeWitt, S., Eward, W. C., Eward, C. A., Lazarides, A. L., Whitley, M. J., Ferrer, J. M., … Berg, J. (2016). A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs. Vet Surg, 45(6), 715–722. https://doi.org/10.1111/vsu.12487
Bartholf DeWitt, Suzanne, William C. Eward, Cindy A. Eward, Alexander L. Lazarides, Melodi Javid Whitley, Jorge M. Ferrer, Brian E. Brigman, David G. Kirsch, and John Berg. “A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.Vet Surg 45, no. 6 (August 2016): 715–22. https://doi.org/10.1111/vsu.12487.
Bartholf DeWitt S, Eward WC, Eward CA, Lazarides AL, Whitley MJ, Ferrer JM, et al. A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs. Vet Surg. 2016 Aug;45(6):715–22.
Bartholf DeWitt, Suzanne, et al. “A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.Vet Surg, vol. 45, no. 6, Aug. 2016, pp. 715–22. Pubmed, doi:10.1111/vsu.12487.
Bartholf DeWitt S, Eward WC, Eward CA, Lazarides AL, Whitley MJ, Ferrer JM, Brigman BE, Kirsch DG, Berg J. A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs. Vet Surg. 2016 Aug;45(6):715–722.
Journal cover image

Published In

Vet Surg

DOI

EISSN

1532-950X

Publication Date

August 2016

Volume

45

Issue

6

Start / End Page

715 / 722

Location

United States

Related Subject Headings

  • Veterinary Sciences
  • Sarcoma
  • Prospective Studies
  • Neoplasm, Residual
  • Neoplasm Recurrence, Local
  • Mastocytoma
  • Female
  • Dogs
  • Dog Diseases
  • Biopsy